UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 7, 2014
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
| UTAH | 87-0342734 |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 5.03 - AMENDMENT TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR
On February 7, 2014 the Board of Directors of Utah Medical Products, Inc. adopted revised Bylaws that include a new Article XI that provides for an exclusive forum for internal disputes in order to avoid multi-jurisdictional disputes and potential inconsistent results and to promote efficiency and economy in such determinations. Additionally, minor editorial and technical changes were made throughout for consistency with the current language of the Utah Revised Business Corporation Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| UTAH MEDICAL PRODUCTS, INC. | |
| REGISTRANT | |
| Date: 2/13/2014 | By: /s/ Kevin L. Cornwell |
| Kevin L. Cornwell | |
| CEO |
EXHIBIT INDEX
Index
Number Description
| 99.1 | Bylaws of Utah Medical Products, Inc. |